EV portfolio to drive Uno Minda growth
Business Standard|June 07, 2024
The stock of auto component maker Uno Minda jumped 13 per cent on Thursday after it announced a technical licensing agreement with ChinaInovance based Suzhou Automotive Company.
RAM PRASAD SAHU
EV portfolio to drive Uno Minda growth

The company will develop, manufacture, and sell four-wheeler electric powertrain products. Over a one month period, the gains extended to 33 per cent given the better than expected fourth-quarter results in 2023-24 (Q4 FY24).

The immediate trigger for the stock is the technical collaboration with the Chinese company for the manufacture and sale of select high-voltage category electric vehicle products for passenger and commercial vehicles in India. The range of EV products includes the charging control unit, inverter, motors, and three-in-one electric drive systems (e-axle).

The management highlighted that the partnership would significantly expand Uno Minda's e-4W product portfolio, enabling it to effectively cater to the growing Indian EV market. The company is seeking to convert the technical collaboration into a joint venture, going ahead.

Diese Geschichte stammt aus der June 07, 2024-Ausgabe von Business Standard.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der June 07, 2024-Ausgabe von Business Standard.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS BUSINESS STANDARDAlle anzeigen
CDSCO cracks whip on drug units
Business Standard

CDSCO cracks whip on drug units

Shuts down 36% of the 400-odd drug manufacturing facilities for failing to meet quality standards

time-read
2 Minuten  |
June 28, 2024
Business Standard

USFDA flags drug quality concerns in India

The Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA), has expressed concern over the quality of drugs manufactured in India, asserting that it found violations at 11 per cent of the facilities it inspected in the country, the highest in any other global region, a senior official said.

time-read
1 min  |
June 28, 2024
Arundhati Roy gets UK's Pen Pinter Prize
Business Standard

Arundhati Roy gets UK's Pen Pinter Prize

Booker Prize-winning author Arundhati Roy, currently facing the threat of prosecution over historic comments on Kashmir 14 years ago, was on Thursday honoured with the prestigious Pen Pinter Prize 2024 for her \"unflinching and unswerving\" writings.

time-read
1 min  |
June 28, 2024
7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%
Business Standard

7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%

With enhanced revenues, the stage seems set for GST 2.0

time-read
5 Minuten  |
June 28, 2024
Launches may offer shot in arm for GSK Pharma
Business Standard

Launches may offer shot in arm for GSK Pharma

The stock of GlaxoSmithKline Pharmaceuticals, or GSK Pharma, has risen over 5 per cent in a week.

time-read
2 Minuten  |
June 28, 2024
Business Standard

700% surge in 6 mths: 25 SME stocks reach for the sky

Stocks of small and medium enterprises (SME) have had a good run at the bourses, with select counters surging more than 700 per cent in calendar year 2024, according to data from ACE Equity.

time-read
2 Minuten  |
June 28, 2024
Business Standard

Allied Blenders' IPO subscribed 23.5 times

Allied Blenders & Distillers's initial public offering (IPO) was subscribed 23.5 times on Thursday, the concluding day of the issue.

time-read
1 min  |
June 28, 2024
'Tax relief will be big positive for markets'
Business Standard

'Tax relief will be big positive for markets'

All eyes are on Union Budget proposals that will in July show the policy intent of the new government.

time-read
3 Minuten  |
June 28, 2024
Business Standard

Fairfax group divests 9.7% stake in CSB Bank

Canadian billionaire Prem Watsa's Fairfax group on Thursday divested a 9.7 per cent stake in CSB Bank through its arm FIH Mauritius Investments.

time-read
1 min  |
June 28, 2024
Dr Reddy's in pink of health after Haleon's NRT biz acquisition
Business Standard

Dr Reddy's in pink of health after Haleon's NRT biz acquisition

Dr Reddy's Laboratories (DRL) is set to acquire Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.

time-read
2 Minuten  |
June 28, 2024